Profile
Clayton Robertson worked as an Analyst at Trout Capital LLC.
Served as Investor Relations Contact at Achillion Pharmaceuticals, Inc. from 2019 to 2020.
Worked as Director-Investor Relations at PureTech Health Plc in 2020.
Worked as Director-Investor Relations at Actinium Pharmaceuticals, Inc. from 2020 to 2021.
Worked as Head-Investor Relations at Immunocore Holdings Plc from 2021 to 2026.
Completed undergraduate education at the University of Pennsylvania.
Former positions of Clayton Robertson
| Companies | Position | End |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Investor Relations Contact | 31/01/2026 |
| ACTINIUM PHARMACEUTICALS, INC. | Investor Relations Contact | 31/01/2021 |
| PURETECH HEALTH PLC | Investor Relations Contact | 31/07/2020 |
| ACHILLION PHARMACEUTICALS, INC. | Investor Relations Contact | 30/04/2020 |
Trout Capital LLC
Trout Capital LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Training of Clayton Robertson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Achillion Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trout Capital LLC
Trout Capital LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
PureTech Health Plc
PureTech Health Plc BiotechnologyHealth Technology Engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy and autoimmune | Health Technology |
Immunocore Holdings Plc
Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
- Stock Market
- Insiders
- Clayton Robertson
















